Liraglutide appears to reduce brain shrinkage in people with early-stage Alzheimer’s, a small UK study reports
A weight-loss drug could help slow the loss of brain volume in people with Alzheimer’s disease, according to a small study.
Liraglutide, which can also be prescribed for diabetes, is typically taken as an injection once a day.
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
The Maga-flavoured faux pas that shook the games industry